Cargando…

Approaching 10 years disease-free survival after isolated thoracic perfusion for advanced stage IV tonsil carcinoma: A case report

INTRODUCTION: This is a report about the first case of an advanced stage IV tonsil carcinoma treated with isolated thoracic perfusion and chemofiltration. PRESENTATION OF CASE: The tumor extended beyond the midline with bilateral lymphnode metastases. Playing on wind instruments was impossible. As a...

Descripción completa

Detalles Bibliográficos
Autores principales: Aigner, Karl R., Selak, Emir, Aigner, Kornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490995/
https://www.ncbi.nlm.nih.gov/pubmed/32919332
http://dx.doi.org/10.1016/j.ijscr.2020.08.058
_version_ 1783582131689095168
author Aigner, Karl R.
Selak, Emir
Aigner, Kornelia
author_facet Aigner, Karl R.
Selak, Emir
Aigner, Kornelia
author_sort Aigner, Karl R.
collection PubMed
description INTRODUCTION: This is a report about the first case of an advanced stage IV tonsil carcinoma treated with isolated thoracic perfusion and chemofiltration. PRESENTATION OF CASE: The tumor extended beyond the midline with bilateral lymphnode metastases. Playing on wind instruments was impossible. As a professional Jazz saxophonist he refused mutilating surgery and chemoradiotherapy. After one isolated thoracic perfusion there was substantial tumor shrinkage. After three additional cycles of carotid artery infusion with chemofiltration a complete remission has been noted without systemic or local toxicity since 9 ½ years. DISCUSSION: Knowing the often considerable long-term damage after surgery and chemoradiotherapy of head and neck tumors, some patient reject conventional therapy. Because of the steep dose response curve in cancer chemotherapy, an increased drug exposure in terms of intra-arterial short-term infusions or isolated perfusion can induce rapid remission induction without significantly affecting the quality of life. Further studies comparing regional chemotherapies with conventional chemoradiotherapy are warranted. CONCLUSION: Intra-arterially applied short-term chemotherapy may generate rapid and onlasting remissions at low side-effects.
format Online
Article
Text
id pubmed-7490995
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-74909952020-09-21 Approaching 10 years disease-free survival after isolated thoracic perfusion for advanced stage IV tonsil carcinoma: A case report Aigner, Karl R. Selak, Emir Aigner, Kornelia Int J Surg Case Rep Case Report INTRODUCTION: This is a report about the first case of an advanced stage IV tonsil carcinoma treated with isolated thoracic perfusion and chemofiltration. PRESENTATION OF CASE: The tumor extended beyond the midline with bilateral lymphnode metastases. Playing on wind instruments was impossible. As a professional Jazz saxophonist he refused mutilating surgery and chemoradiotherapy. After one isolated thoracic perfusion there was substantial tumor shrinkage. After three additional cycles of carotid artery infusion with chemofiltration a complete remission has been noted without systemic or local toxicity since 9 ½ years. DISCUSSION: Knowing the often considerable long-term damage after surgery and chemoradiotherapy of head and neck tumors, some patient reject conventional therapy. Because of the steep dose response curve in cancer chemotherapy, an increased drug exposure in terms of intra-arterial short-term infusions or isolated perfusion can induce rapid remission induction without significantly affecting the quality of life. Further studies comparing regional chemotherapies with conventional chemoradiotherapy are warranted. CONCLUSION: Intra-arterially applied short-term chemotherapy may generate rapid and onlasting remissions at low side-effects. Elsevier 2020-09-03 /pmc/articles/PMC7490995/ /pubmed/32919332 http://dx.doi.org/10.1016/j.ijscr.2020.08.058 Text en © 2020 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Aigner, Karl R.
Selak, Emir
Aigner, Kornelia
Approaching 10 years disease-free survival after isolated thoracic perfusion for advanced stage IV tonsil carcinoma: A case report
title Approaching 10 years disease-free survival after isolated thoracic perfusion for advanced stage IV tonsil carcinoma: A case report
title_full Approaching 10 years disease-free survival after isolated thoracic perfusion for advanced stage IV tonsil carcinoma: A case report
title_fullStr Approaching 10 years disease-free survival after isolated thoracic perfusion for advanced stage IV tonsil carcinoma: A case report
title_full_unstemmed Approaching 10 years disease-free survival after isolated thoracic perfusion for advanced stage IV tonsil carcinoma: A case report
title_short Approaching 10 years disease-free survival after isolated thoracic perfusion for advanced stage IV tonsil carcinoma: A case report
title_sort approaching 10 years disease-free survival after isolated thoracic perfusion for advanced stage iv tonsil carcinoma: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490995/
https://www.ncbi.nlm.nih.gov/pubmed/32919332
http://dx.doi.org/10.1016/j.ijscr.2020.08.058
work_keys_str_mv AT aignerkarlr approaching10yearsdiseasefreesurvivalafterisolatedthoracicperfusionforadvancedstageivtonsilcarcinomaacasereport
AT selakemir approaching10yearsdiseasefreesurvivalafterisolatedthoracicperfusionforadvancedstageivtonsilcarcinomaacasereport
AT aignerkornelia approaching10yearsdiseasefreesurvivalafterisolatedthoracicperfusionforadvancedstageivtonsilcarcinomaacasereport